Đang chuẩn bị liên kết để tải về tài liệu:
Survival time following resection of intracranial metastases from NSCLCdevelopment and validation of a novel nomogram

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Brain metastases (BM) from non-small cell lung cancer (NSCLC) are the most frequent intracranial tumors. To identify patients who might benefit from intracranial surgery, we compared the six existing prognostic indexes(PIs) and built a nomogram to predict the survival for NSCLC with BM before they intended to receive total intracranial resection in China. | Survival time following resection of intracranial metastases from NSCLCdevelopment and validation of a novel nomogram

TÀI LIỆU LIÊN QUAN

Time-dependent endpoints as predictors of overall survival in multiple myeloma

The Norwegian dietary guidelines and colorectal cancer survival (CRC-NORDIET) study: A food-based multicentre randomized controlled trial

Time from diagnosis to surgery and prostate cancer survival: A retrospective cohort study

Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice

Loneliness and survival of happiness seekers: A conceptualisation with mood-influenced returns on health-dependent active-time

Studies on the mode of survival of diplocarpon mali causing premature leaf fall of apple

Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome

Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma

Oral cancer incidence and survival rates in the Republic of Ireland, 1994-2009

Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: Impact on survival
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.